Craig A. Johnson - Jan 14, 2022 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
Director
Signature
/s/ Vickie Reed, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Jan 14, 2022
Transactions value $
$0
Form type
4
Date filed
1/18/2022, 05:20 PM
Previous filing
Jan 14, 2022
Next filing
Jul 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Award $0 +2.55K +73.27% $0.00 6.02K Jan 14, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRTX Non Qualified Stock Option (right to buy) Award $0 +3.69K $0.00 3.69K Jan 14, 2022 Common Stock 3.69K $124.31 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of Restricted Stock Units (RSUs). Shares will vest 100% on the anniversary of the grant date.
F2 The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant.